Experienced in Cramp-Fasciculation Syndrome

Tim Hagenacker

Essen, NW, DE 
Experienced in Cramp-Fasciculation Syndrome
Essen, NW, DE 
OverviewLocationsClinical Research

Overview

Tim Hagenacker practices in Essen, Germany. Mr. Hagenacker is rated as an Experienced expert by MediFind in the treatment of Cramp-Fasciculation Syndrome. His top areas of expertise are Spinal Muscular Atrophy (SMA), Primary Lateral Sclerosis, Muscle Atrophy, Tissue Biopsy, and Spinal Fusion.

His clinical research consists of co-authoring 123 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Cramp-Fasciculation Syndrome.

Gender
Male

Locations

Essen, NW, Germany
Other Locations
Duisburg, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
A Phase 1, Blinded, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of BIIB132 Administered Intrathecally to Adults With Spinocerebellar Ataxia 3
Enrollment Status: Terminated
Publish Date: August 04, 2023
Intervention Type: Drug
Study Drug: BIIB132
Study Phase: Phase 1

123 Total Publications

Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.
Choosing the optimal mouse model for the study of late-onset spinal muscular atrophy: Why the 4-copy SMN2 model offers ideal translational relevance.
Journal: Journal of neuromuscular diseases
Published: January 16, 2026

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hagenacker's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile